Trademark: ALLIANCE FOR CANCER GENE THERAPY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
ALLIANCE FOR CANCER GENE THERAPY
Click here to search for trademarks similar to ALLIANCE FOR CANCER GENE THERAPY
Proof of use for ALLIANCE FOR CANCER GENE THERAPY
We do not have any records of a proof of use for ALLIANCE FOR CANCER GENE THERAPY at this moment.
Click here to add a proof of use for ALLIANCE FOR CANCER GENE THERAPY
Possible trademark infringements of ALLIANCE FOR CANCER GENE THERAPY
Basic Information about ALLIANCE FOR CANCER GENE THERAPY
- Serial Number
- 76254813
- Filing Date
- 10 May 2001
- Registration Number
- 2641301
- Registration Date
- 22 Oct 2002
- Mark Drawing Code
- 1
Classifications
Declare the trademark use of ALLIANCE FOR CANCER GENE THERAPY on the blockchain with WikiTrademarks.io.
- First use of ALLIANCE FOR CANCER GENE THERAPY anywhere
- ALLIANCE FOR CANCER GENE THERAPY was first used on 01 Mar 2002 for the primary classification of goods and services, international, 036 (Insurance and financial)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 036
- US Codes
- 100; 101; 102
Who owns ALLIANCE FOR CANCER GENE THERAPY?
Correspondent
- Stewart L. Gitler
- WELSH FLAXMAN & GITLER LLC
- 2000 DUKE STREET
- SUITE 100
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io